L. Diaz

The Design and Rationale of a Phase 2b, Randomized, Double-Blinded, and Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Lomecel-B in Older Adults with Frailty

A. Newman, J. Walston, B. Hitchinson, 2022, The Journal of Frailty & Aging.

Safety and efficacy of Lomecel‐B in patients with mild Alzheimer’s disease: Results of a double‐blinded, randomized, placebo‐controlled phase 1 clinical trial

Tyler J. Wishard, S. Bookheimer, Keyvan Yousefi, 2021, Alzheimer's & Dementia.